摘要
利脉饮通过对动脉粥样硬化发病学相关因素影响的实验观察,结果表明本品对高脂血大鼠的TC、TG有轻度下降,却能显著提高HDL2的含量;对大鼠体外PAgT的抑制极为明显,并能提高小鼠SOD的活力和降低LPO的含量,抑制MDA的生成和XOD活力等,故对防治AS。
The experimental study on the interrelative factors of Limaiyin against atherosclerosis showed that the total .amount of serum cholesterol was slightly decreased and HDL2-C wassignificantly incrgased in rats fed with diets rich in cholesterol. The results also showed thatLimaiyin obviously inhibited the platelet aggregation if rats induced by ADP, the formation ofplatelet MDA, and the activity of XOD in flyer and kidneys of mice. This indicated that Limaiyin could regulate the metabolism of Lipid and free radical and reduce atherosclerosis, preventthe formation of artery thrombus, scavenge free radical, postpone aging, and stabilize the metabolism of uric acid.
关键词
利脉饮
动脉粥样硬化
药理学
Limaiyin
Atherosclerosis HDL2-C
SOD LPO MDA XOD